DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Econochlor (Chloramphenicol Ophthalmic) - Published Studies

 
 



Econochlor Related Published Studies

Well-designed clinical trials related to Econochlor (Chloramphenicol Ophthalmic)

Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. [2011.06]

Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial. [2009.01.15]

Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). [2008.01.12]

Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico. [2007.11]

Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. [2005.10]

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. [2005.07.23]

Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. [2005.07.02]

A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. [2005.06]

Well-designed clinical trials possibly related to Econochlor (Chloramphenicol Ophthalmic)

New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. [2012]

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2011.10.05]

Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics. [2011.08.01]

Pharmacokinetics of a florfenicol-tylosin combination after intravenous and intramuscular administration to beagle dogs. [2011.04]

Effects of dietary antibiotic growth promoter and Saccharomyces cerevisiae fermentation product on production, intestinal bacterial community, and nonspecific immunity of hybrid tilapia (Oreochromis niloticus female x Oreochromis aureus male). [2011.01]

In vivo assessment of the effect of an adhesive for complete dentures on colonisation of Candida species. [2010.12]

Antibiotic use in obstetric fistula repair: single blinded randomized clinical trial. [2010.07]

Efficacy of florfenicol for control of mortality caused by Flavobacterium columnare infection in channel catfish. [2010.06]

Nasopharyngeal carriage of S. pneumoniae among young children in rural Nepal. [2009.09]

Aerosol antibiotic therapy in children with chronic upper airway infections: a potential alternative to surgery. [2009.04]

The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. [2009.03]

Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). [2008.10.08]

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2008.10.08]

Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. [2008.07]

Dental amalgam and antibiotic- and/or mercury-resistant bacteria. [2008.05]

Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs. [2008.02]

Influence of povidone-iodine preoperative showers on skin colonization in elective plastic surgery procedures. [2008.01]

A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). [2007.07]

An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska. [2007.06]

Effects of Saccharomyces cerevisiae subspecies boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers. [2007.05]

Efficacy of enrofloxacin, florfenicol and amoxicillin against Ornithobacterium rhinotracheale and Escherichia coli O2:K1 dual infection in turkeys following APV priming. [2007.03.31]

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. [2007.03]

[Nasal carriage of Streptococcus pneumoniae in elderly subjects according to vaccination status.] [2007.02]

Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits. [2007.02]

Residue depletion of florfenicol and its metabolite florfenicol amine in Swine tissues after intramuscular administration. [2006.12.13]

Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics. [2006.12]

A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. [2006.08.12]

Comparison of the efficacy of four antimicrobial treatment schemes against experimental Ornithobacterium rhinotracheale infection in turkey poults pre-infected with avian pneumovirus. [2006.06]

Post-operative sequelae of lower third molar removal: a literature review and pilot study on the effect of Covomycin D. [2006.05]

Assessing the effect of a single dose florfenicol treatment in feedlot cattle on the antimicrobial resistance patterns in faecal Escherichia coli. [2005.09]

Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. [2005.07]

Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe. [2005.06]

Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. [2005.06]

Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. [2005.06]

Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. [2005.06]

Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle. [2005.06]

Role of topical antibiotics in hip surgery. A prospective randomised study. [2005.06]

[Changes in bacterial flora of conjunctival sac in patients prophylacticaly treated with antibiotic before cataract operation] [2005]

Other research related to Econochlor (Chloramphenicol Ophthalmic)

Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Fucidic acid or chloramphenicol for neonates with sticky eyes. [2011.07]

Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. [2011]

Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. [2011]

Successful treatment of vancomycin-resistant Enterococcus faecium ventriculitis with combined intravenous and intraventricular chloramphenicol in a newborn. [2010.11]

Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability. [2010.10]

Role of oxidative stress in reproductive toxicity induced by co-administration of chloramphenicol and multivitamin-haematinics complex in rats. [2010.09]

Is chloramphenicol making a comeback? [2010.06]

Changing antibiotic sensitivity pattern and scope of chloramphenicol in the management of hospitalised patients of typhoid fever. [2009.12]

Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis. [2009.12]

Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release. [2009.07]

Toxic effect and adaptation in Scenedesmus intermedius to anthropogenic chloramphenicol contamination: genetic versus physiological mechanisms to rapid acquisition of xenobiotic resistance. [2009.07]

A structural study of the interaction between the Dr haemagglutinin DraE and derivatives of chloramphenicol. [2009.06]

Depletion of chloramphenicol in trout after a hypothetic therapeutic treatment. [2009.04.01]

The bacterial Tn9 chloramphenicol resistance gene: an attractive DNA segment for Mos1 mariner insertions. [2008.12.27]

Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis. [2008.11]

Monitoring of Leuconostoc mesenteroides DRC starter in fermented vegetable by random integration of chloramphenicol acetyltransferase gene. [2008.09]

Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications. [2008.07]

Monitoring of Leuconostoc mesenteroides DRC starter in fermented vegetable by random integration of chloramphenicol acetyltransferase gene. [2008.05.24]

Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. [2008.05]

Anterior uveitis, poliosis, and skin hypopigmentation associated with topical chloramphenicol allergy following ptosis surgery. [2007.07]

Pharmacokinetics of florfenicol, thiamphenicol, and chloramphenicol in turkeys. [2007.04]

Chloramphenicol: screening and review to evaluate its potential beneficial effects in leukaemia. [2007.04]

A competitive enzyme-linked immunosorbent assay for determination of chloramphenicol. [2007.02]

Chloramphenicol pharmacokinetics in African children with severe malaria. [2006.08]

Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse. [2006.04]

Does long-term chloramphenicol cause anaemia in Malawi? [2006.04]

Management of anemic effects of chloramphenicol using amino acids on albino rats infected with Salmonella typhi. [2006.03]

Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome. [2006.03]

Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. [2006.01]

[Inter-laboratory validation studies of biological method for determination of streptomycin in royal jelly] [2005.12]

Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics. [2005.11.28]

Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited. [2005.10]

Effects of light and chloramphenicol stress on incorporation of nitrogen into cyanophycin in Synechocystis sp. strain PCC 6308. [2005.09.15]

Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. [2005.09.14]

Other possibly related research studies

A Versatile photocleavable bifunctional linker for facile synthesis of substrate-DNA conjugates for the selection of nucleic acid catalysts. [2007.01]

Scientific challenges in postmarketing surveillance of ocular adverse drug reactions. [2007.01]

Cloning and characterization of promoter-active DNA sequences from Streptococcus equisimilis. [2007.01]

Treating experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua L., with florfenicol. [2006.12]

A randomised controlled comparison of ofloxacin, azithromycin and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid resistant typhoid fever. [2006.12.04]

Antibiotic drug interactions. [2006.11]

Invasive pneumococcal disease in children<5 years of age in rural Mozambique. [2006.09]

Detergent capsules causing ocular injuries in children. [2006.07]

[Resistance to antimicrobial drugs in Enterococcus sp. strains isolated in hospitals of Northern Chile] [2006.09]

Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. [2006.07]

Ocular methicillin-resistant Staphylococcus aureus infections in a newborn intensive care cohort. [2006.07]

Inhibition of protein and RNA synthesis in Escherichia coli results in declustering of plasmid RK2. [2006.09]

Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. [2006.06]

Corneal ulceration in South East Asia. II: a strategy for the prevention of fungal keratitis at the village level in Burma. [2006.08]

Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A. [2006.04]

Cutaneous myospherulosis and membranous lipodystrophy: extensive presentation in a patient with severe steroid-induced dermal atrophy. [2006.04]

[Molecular mechanism of multiple-drug and pan-drug resistance among Acinetobacter species] [2006.01.03]

Old dogs that learn new tricks: modified antimicrobial agents that escape pre-existing resistance mechanisms. [2006.06]

[Rickettsialpox: report of two cases imported from South Africa] [2005.12]

Corneal ulceration in South East Asia. I: a model for the prevention of bacterial ulcers at the village level in rural Bhutan. [2006.03]

Biosynthetic requirements for the repair of sublethal membrane damage in Escherichia coli cells after pulsed electric fields. [2006.03]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012